Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
$815.54
$1.72(0.29%)
At close: 4:00 PM EST
$815.54
$1.72(0.29%)
Day’s Range― - ―
52-Week Range$558.13 - $895.58
Previous CloseN/A
Volume137.88K
Average Volume (3M)819.78K
Market Cap
$100.36B
Enterprise Value$102.95B
Total Cash (Recent Filing)$4.11B
Total Debt (Recent Filing)$9.79B
Price to Earnings (P/E)25.3
Beta0.25
Next Earnings
Feb 04, 2026EPS Estimate
9.16Last Dividend Ex-Date
Dec 01, 2025Dividend Yield0.38%
Share Statistics
EPS (TTM)9.86
Shares Outstanding123,426,650
10 Day Avg. Volume834,375
30 Day Avg. Volume819,783
Financial Highlights & Ratios
PEG Ratio1.77
Price to Book (P/B)-41.34
Price to Sales (P/S)0.24
P/FCF Ratio16.41
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit7.94
Enterprise Value/Ebitda17.50
Forecast
1Y Price Target
$935.33Price Target Upside14.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)38.69
Revenue Forecast (FY)$408.20B
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceMcKesson raised its full-year adjusted earnings per share guidance, indicating management's confidence in future performance.
Market PositioningInvestments in oncology, multispecialty, and biopharma are expected to have higher margins and offer a long runway for growth.
Oncology GrowthThe robust pipeline of specialty drug launches in oncology, neurology, and rare diseases is anticipated to support growth.
Bears Say
Industry ChallengesThe potential spin-off of MedSurg faces challenges due to competition and industry trends, which are seen as somewhat challenging.
Segment PerformanceMed Surg AOI of $249M missed consensus of $255M.
Valuation ConcernsMedSurg peers trade at a discount to MCK’s current valuation, posing a significant obstacle to further multiple expansion.
McKesson News
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $558.13 and its highest was $895.58 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $100.36B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Feb 04, 2026 which is in 53 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Nov 05, 2025. The company reported $9.86 earnings per share for the quarter, beating the consensus estimate of $9.03 by $0.83.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.82 which represents an annual dividend yield of 0.38%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.16.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 123,426,650 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $9.86 in its last earnings report, beating expectations of $9.03. Following the earnings report the stock price went up 1.7%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$935.33 (14.69% Upside)
$935.33 (14.69% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 87%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 9.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
16.20%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation is a global leader in healthcare supply chain management, dedicated to improving healthcare delivery through its extensive network of services. The company operates primarily in two segments: pharmaceutical distribution and medical-surgical distribution. McKesson provides a wide range of pharmaceutical products, including prescription and over-the-counter medications, as well as healthcare management software and automation solutions. Its core services support pharmacies, hospitals, and healthcare providers by ensuring they have the necessary products and services to deliver quality care.
MCK Company Deck
MCK Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
McKesson reported strong financial performance with significant growth in revenue and earnings, driven by robust performance in oncology and multispecialty segments and prescription technology solutions. The company raised its earnings guidance, reflecting confidence in continued growth. However, challenges in the Medical-Surgical Solutions segment present some concerns. Overall, the strengths significantly outweigh the challenges.View all MCK earnings summariesMCK Revenue Breakdown
91.27% U.S. Pharmaceutical
1.45% Prescription Technology Solutions
3.17% Medical-Surgical Solutions
4.10% International
<0.01% Corporate
MCK Stock 12 Month Forecast
Average Price Target
$935.33
▲(14.69% Upside)
Technical Analysis
Cencora
―
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Prestige Consumer Healthcare
―
Ownership Overview
0.03% Insiders
24.76% Mutual Funds
7.34% Other Institutional Investors
45.94% Public Companies and Individual Investors